XML 70 R61.htm IDEA: XBRL DOCUMENT
v3.24.3

At-the-Market Equity Offerings - Summary of Active At-the-Market Equity Offering (Detail) - USD ($) |  |  |  |  |  |  |  | 2 Months Ended | 3 Months Ended | 4 Months Ended | 8 Months Ended | 9 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Aug. 01, 2024 | Jul. 31, 2024 | Nov. 30, 2023 | Nov. 29, 2023 | Aug. 01, 2023 | May 01, 2023 | Sep. 09, 2022 | Sep. 30, 2024 | Sep. 30, 2024 | Sep. 30, 2023 | Jul. 31, 2023 | Nov. 29, 2023 | Jul. 31, 2024 | May 01, 2023 | Sep. 30, 2024 | Sep. 30, 2023 | Dec. 31, 2023
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds received from shares sold under such sales agreement |  |  |  |  |  |  |  |  | $ 1,105,141,000 | $ 147,218,000 |  |  |  |  | $ 1,242,293,000 | $ 819,674,000 |
Class A |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cumulative shares sold under such sales agreement |  |  |  |  |  |  |  | 191,684,000 | 191,684,000 |  |  |  |  |  | 191,684,000 |  | 157,725,000
August 2024 Sales Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds received from shares sold under such sales agreement |  |  |  |  |  |  |  |  | $ 1,105,141,000 |  |  |  |  |  | $ 1,105,141,000 |  |
Cumulative shares sold under such sales agreement |  |  |  |  |  |  |  | 8,048,449 | 8,048,449 |  |  |  |  |  | 8,048,449 |  |
August 2024 Sales Agreement | TD Securities (USA) LLC, The Benchmark Company, LLC, BTIG, LLC, Canaccord Genuity LLC, Maxim Group LLC and SG Americas Securities, LLC |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds received from shares sold under such sales agreement |  |  |  |  |  |  |  | $ 1,105,141,000 |  |  |  |  |  |  |  |  |
August 2024 Sales Agreement | TD Securities (USA) LLC, The Benchmark Company, LLC, BTIG, LLC, Canaccord Genuity LLC, Maxim Group LLC and SG Americas Securities, LLC | Class A |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Agreement effective date | Aug. 01, 2024 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum aggregate offering price | $ 2,000,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum commissions payable to sales agents on gross proceeds from the sale of shares | 2.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum aggregate offering price remaining available for sale under such sales agreement | $ 891,286 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
November 2023 Sales Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds received from shares sold under such sales agreement |  |  |  |  |  |  |  |  | $ 0 |  |  |  |  |  | $ 137,152,000 |  |
Cumulative shares sold under such sales agreement |  |  |  |  |  |  |  | 12,720,770 | 12,720,770 |  |  |  |  |  | 12,720,770 |  |
November 2023 Sales Agreement | Cowen and Company LLC, Canaccord Genuity LLC, and BTIG, LLC |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds received from shares sold under such sales agreement |  |  |  |  |  |  |  |  |  |  |  |  | $ 747,025,000 |  |  |  |
November 2023 Sales Agreement | Cowen and Company LLC, Canaccord Genuity LLC, and BTIG, LLC | Class A |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Agreement effective date |  |  | Nov. 30, 2023 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum aggregate offering price |  |  | $ 750,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum commissions payable to sales agents on gross proceeds from the sale of shares |  |  | 2.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |
Date terminated |  | Jul. 31, 2024 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
August 2023 Sales Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds received from shares sold under such sales agreement |  |  |  |  |  |  |  |  |  | 147,218,000 |  |  |  |  |  | 147,218,000 |
Cumulative shares sold under such sales agreement |  |  |  |  |  |  |  | 15,929,500 | 15,929,500 |  |  |  |  |  | 15,929,500 |  |
August 2023 Sales Agreement | Cowen, Canaccord and Berenberg Capital Markets LLC |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds received from shares sold under such sales agreement |  |  |  |  |  |  |  |  |  |  |  | $ 737,760,000 |  |  |  |  |
August 2023 Sales Agreement | Cowen, Canaccord and Berenberg Capital Markets LLC | Class A |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Agreement effective date |  |  |  |  | Aug. 01, 2023 |  |  |  |  |  |  |  |  |  |  |  |
Maximum aggregate offering price |  |  |  |  | $ 750,000,000 |  |  |  |  |  |  |  |  |  |  |  |
Maximum commissions payable to sales agents on gross proceeds from the sale of shares |  |  |  |  | 2.00% |  |  |  |  |  |  |  |  |  |  |  |
Date terminated |  |  |  | Nov. 29, 2023 |  |  |  |  |  |  |  |  |  |  |  |  |
May 2023 Sales Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds received from shares sold under such sales agreement |  |  |  |  |  |  |  |  |  | $ 0 |  |  |  |  |  | 333,494,000 |
Cumulative shares sold under such sales agreement |  |  |  |  |  |  |  | 10,791,700 | 10,791,700 |  |  |  |  |  | 10,791,700 |  |
May 2023 Sales Agreement | Cowen and Canaccord Genuity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds received from shares sold under such sales agreement |  |  |  |  |  |  |  |  |  |  | $ 333,494,000 |  |  |  |  |  |
May 2023 Sales Agreement | Cowen and Canaccord Genuity | Class A |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Agreement effective date |  |  |  |  |  | May 01, 2023 |  |  |  |  |  |  |  |  |  |  |
Maximum aggregate offering price |  |  |  |  |  | $ 625,000,000 |  |  |  |  |  |  |  |  |  |  |
Maximum commissions payable to sales agents on gross proceeds from the sale of shares |  |  |  |  |  | 2.00% |  |  |  |  |  |  |  |  |  |  |
Date terminated |  |  |  |  | Aug. 01, 2023 |  |  |  |  |  |  |  |  |  |  |  |
2022 Sales Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds received from shares sold under such sales agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 338,962,000 |
Cumulative shares sold under such sales agreement |  |  |  |  |  |  |  | 15,674,300 | 15,674,300 |  |  |  |  |  | 15,674,300 |  |
2022 Sales Agreement | Cowen and Canaccord Genuity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds received from shares sold under such sales agreement |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 385,181,000 |  |  |
2022 Sales Agreement | Cowen and Canaccord Genuity | Class A |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
At Market Equity Offerings [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Agreement effective date |  |  |  |  |  |  | Sep. 09, 2022 |  |  |  |  |  |  |  |  |  |
Maximum aggregate offering price |  |  |  |  |  |  | $ 500,000,000 |  |  |  |  |  |  |  |  |  |
Maximum commissions payable to sales agents on gross proceeds from the sale of shares |  |  |  |  |  |  | 2.00% |  |  |  |  |  |  |  |  |  |
Date terminated |  |  |  |  |  | May 01, 2023 |  |  |  |  |  |  |  |  |  |  |

X
- Definition At-the-market equity offerings. + References No definition available. + Details
Name: | mstr_AtMarketEquityOfferingsLineItems
Namespace Prefix: | mstr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Common stock shares ATM authorized value. + References No definition available. + Details
Name: | mstr_CommonStockSharesATMAuthorizedValue
Namespace Prefix: | mstr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Common stock shares atm authorized remaining value. + References No definition available. + Details
Name: | mstr_CommonStockSharesAtmAuthorizedRemainingValue
Namespace Prefix: | mstr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The maximum commission percentage on sales under the open market sale agreement.. + References No definition available. + Details
Name: | mstr_MaximumCommissionPercentageATMStockSales
Namespace Prefix: | mstr_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Proceeds from issuance or sale of equity net. + References No definition available. + Details
Name: | mstr_ProceedsFromIssuanceOrSaleOfEquityNet
Namespace Prefix: | mstr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Sales agreement effective date. + References No definition available. + Details
Name: | mstr_SalesAgreementEffectiveDate
Namespace Prefix: | mstr_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Sales agreement termination date. + References No definition available. + Details
Name: | mstr_SalesAgreementTerminationDate
Namespace Prefix: | mstr_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=mstr_August2024SalesAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mstr_TdSecuritiesUsaLlcTheBenchmarkCompanyLlcBtigLlcCanaccordGenuityLlcMaximGroupLlcAndSgAmericasSecuritiesLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=mstr_November2023SalesAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mstr_CowenAndCompanyLLCCanaccordGenuityLLCAndBtigLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=mstr_August2023SalesAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mstr_CowenAndCompanyLLCCanaccordGenuityLLCAndBerenbergCapitalMarketsLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=mstr_May2023SalesAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mstr_CowenAndCompanyLLCAndCanaccordGenuityLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=mstr_TwoThousandTwentyTwoSalesAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |